Literature DB >> 27090639

Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.

Hendrick Soh1, Natarajan Venkatesan1, Mysore S Veena2, Sandhiya Ravichandran1, Alborz Zinabadi1, Saroj K Basak2, Kislay Parvatiyar3, Meera Srivastava4, Li-Jung Liang2, David W Gjertson5, Jorge Z Torres6, Neda A Moatamed5, Eri S Srivatsan7.   

Abstract

We and others have shown that the cystatin E/M gene is inactivated in primary human tumors, pointing to its role as a tumor suppressor gene. However, the molecular mechanism of tumor suppression is not yet understood. Using plasmid-directed cystatin E/M gene overexpression, a lentivirus-mediated tetracycline-inducible vector system, and human papillomavirus 16 (HPV 16) E6 and E7 gene-immortalized normal human epidermal keratinocytes, we demonstrated intracellular and non-cell-autonomous apoptotic growth inhibition of tumor cell lines and that growth inhibition is associated with cytoplasmic retention of NF-κB. We further demonstrated decreased phosphorylation of IκB kinase (IKKβ) and IκBα in the presence of tumor necrosis factor alpha (TNF-α), confirming the role of cystatin E/M in the regulation of the NF-κB signaling pathway. Growth suppression of nude mouse xenograft tumors carrying a tetracycline-inducible vector system was observed with the addition of doxycycline in drinking water, confirming that the cystatin E/M gene is a tumor suppressor gene. Finally, immunohistochemical analyses of cervical carcinoma in situ and primary tumors have shown a statistically significant inverse relationship between the expression of cystatin E/M and cathepsin L and a direct relationship between the loss of cystatin E/M expression and nuclear expression of NF-κB. We therefore propose that the cystatin E/M suppressor gene plays an important role in the regulation of NF-κB.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27090639      PMCID: PMC4907098          DOI: 10.1128/MCB.00878-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.

Authors:  Tsing Cheng; Kiyotaka Hitomi; Ivonne M J J van Vlijmen-Willems; Gys J de Jongh; Kanae Yamamoto; Koji Nishi; Colin Watts; Thomas Reinheckel; Joost Schalkwijk; Patrick L J M Zeeuwen
Journal:  J Biol Chem       Date:  2006-03-24       Impact factor: 5.157

2.  Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma.

Authors:  B Stabuc; Z Mrevlje; J Markovic; M Stabuc-Silih
Journal:  Neoplasma       Date:  2006       Impact factor: 2.575

3.  Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.

Authors:  Elaine M Smith; Michael Pawlita; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Int J Cancer       Date:  2010-07-01       Impact factor: 7.396

Review 4.  Multiple infections and cancer: implications in epidemiology.

Authors:  Vidya Vedham; Rao L Divi; Vaurice L Starks; Mukesh Verma
Journal:  Technol Cancer Res Treat       Date:  2013-08-02

5.  Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.

Authors:  Jingxin Qiu; Lingbao Ai; Cheppail Ramachandran; Bing Yao; Suhasni Gopalakrishnan; C Robert Fields; Amber L Delmas; Lisa M Dyer; Steven J Melnick; Anthony T Yachnis; Philip H Schwartz; Howard A Fine; Kevin D Brown; Keith D Robertson
Journal:  Lab Invest       Date:  2008-07-07       Impact factor: 5.662

6.  Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy.

Authors:  Wendy Potts; Jonathan Bowyer; Huw Jones; David Tucker; Anthony J Freemont; Andrew Millest; Colin Martin; Wendy Vernon; Diane Neerunjun; Gillian Slynn; Fiona Harper; Rose Maciewicz
Journal:  Int J Exp Pathol       Date:  2004-04       Impact factor: 1.925

7.  Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum.

Authors:  A Anastasi; M A Brown; A A Kembhavi; M J Nicklin; C A Sayers; D C Sunter; A J Barrett
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

8.  Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.

Authors:  Magdalini Kioulafa; Ioanna Balkouranidou; Georgia Sotiropoulou; Loukas Kaklamanis; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

Authors:  Brian J Zarnegar; Yaya Wang; Douglas J Mahoney; Paul W Dempsey; Herman H Cheung; Jeannie He; Travis Shiba; Xiaolu Yang; Wen-Chen Yeh; Tak W Mak; Robert G Korneluk; Genhong Cheng
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  9 in total

1.  Identification of lncRNA-associated differential subnetworks in oesophageal squamous cell carcinoma by differential co-expression analysis.

Authors:  Wei Liu; Cai-Yan Gan; Wei Wang; Lian-Di Liao; Chun-Quan Li; Li-Yan Xu; En-Min Li
Journal:  J Cell Mol Med       Date:  2020-03-12       Impact factor: 5.310

2.  Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.

Authors:  Ahmed A Mohamed; Shyh-Han Tan; Charles P Xavier; Shilpa Katta; Wei Huang; Lakshmi Ravindranath; Muhammad Jamal; Hua Li; Meera Srivastava; Eri S Srivatsan; Taduru L Sreenath; David G McLeod; Alagarsamy Srinivasan; Gyorgy Petrovics; Albert Dobi; Shiv Srivastava
Journal:  Mol Cancer Res       Date:  2017-06-12       Impact factor: 5.852

3.  Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.

Authors:  Mysore S Veena; Santanu Raychaudhuri; Saroj K Basak; Natarajan Venkatesan; Parameet Kumar; Roopa Biswas; Rita Chakrabarti; Jing Lu; Trent Su; Marcus Gallagher-Jones; Marco Morselli; Haiqing Fu; Matteo Pellegrini; Theodore Goldstein; Mirit I Aladjem; Matthew B Rettig; Sharon P Wilczynski; Daniel Sanghoon Shin; Eri S Srivatsan
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

4.  Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.

Authors:  Janja Završnik; Miha Butinar; Mojca Trstenjak Prebanda; Aleksander Krajnc; Robert Vidmar; Marko Fonović; Anders Grubb; Vito Turk; Boris Turk; Olga Vasiljeva
Journal:  Oncotarget       Date:  2017-04-24

5.  An Immunosuppressive Tick Salivary Gland Protein DsCystatin Interferes With Toll-Like Receptor Signaling by Downregulating TRAF6.

Authors:  Ta Sun; Fanqi Wang; Wen Pan; Qihan Wu; Jingwen Wang; Jianfeng Dai
Journal:  Front Immunol       Date:  2018-06-01       Impact factor: 7.561

6.  Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators.

Authors:  Elise Aasebø; Maria Hernandez-Valladares; Frode Selheim; Frode S Berven; Annette K Brenner; Øystein Bruserud
Journal:  Proteomes       Date:  2018-12-20

7.  Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.

Authors:  Fei Wang; Chuanzhu Zhang; Wei Ge; Guoqiang Zhang
Journal:  J Cell Mol Med       Date:  2019-08-11       Impact factor: 5.310

8.  CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.

Authors:  Xiaoxun Li; Yajun Liang; Cheng Lian; Fangli Peng; Yansen Xiao; Yunfei He; Chengxin Ma; Yuan Wang; Peiyuan Zhang; Yuhan Deng; Yunpeng Su; Cheng Luo; Xiangyin Kong; Qingcheng Yang; Tong Liu; Guohong Hu
Journal:  Theranostics       Date:  2021-10-11       Impact factor: 11.556

9.  Cytokines profile in neonatal and adult wild-type mice post-injection of U. S. pediatric vaccination schedule.

Authors:  S C Bairwa; C A Shaw; M Kuo; J Yoo; L Tomljenovic; H Eidi
Journal:  Brain Behav Immun Health       Date:  2021-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.